Draegerwerk Ag & Co. Kgaa · XETR:DRW8
Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — H1 2026 Earnings Presentation
16 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Jul 30, 2026
Slide 1: H1 Conference Call
H1 Conference Call Drägerwerk AG & Co. KGaA July 30, 2026, Lübeck
Slide 2: Disclaimer
Disclaimer — This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future
Slide 3: Agenda
Agenda — 01 Dräger Business Highlights 02 Financials H1 2026 03 Outlook FY 2026 Drägerwerk AG & Co. KGaA 3
Slide 4: Dräger Business Highlights
01 Dräger Business Highlights Drägerwerk AG & Co. KGaA 4
Slide 5: H1 2026 Highlights
H1 2026 Strong net sales growth – Cash flow and margin earnings more than tripled considerably improved Highlights Continued good demand: order intake slightly increased; medical demand weaker due to major order from Mexico in the prior year; safety significantly better Net sales EBIT Excellent net
Slide 6: Financials H1 2026
02 Financials H1 2026 Drägerwerk AG & Co. KGaA 6
Slide 7: Business development Group
Business development Group Order entry 6M 2025 6M 2026 Change — (€ million) (fx-adj.) Germany 388.0 415.6 +7.1 Net sales (€ million) EMEA 677.5 712.2 +5.1 +8.5% +7.7% Americas 411.2 360.9 -9.8 fx-adj fx-adj +8.6% +6.2% APAC 261.3 258.6 +3.9 nominal nominal 1,603 Total 1,738.0 1,747.3 +1.8 1,510 780
Slide 8: Business development Medical
Business development Medical Order entry 6M 2025 6M 2026 Change — (€ million) (fx-adj.) Germany 212.6 221.3 +4.1 Net sales (€ million) EMEA 339.5 358.2 +5.9 +9.7% +7.6% Americas 290.6 220.1 -22.3 fx-adj fx-adj +9.6% +5.5% APAC 168.1 156.8 -0.8 nominal nominal 898 Total 1,010.8 956.5 -3.7 851 438 480
Slide 9: Business development Safety
Business development Safety Order entry 6M 2025 6M 2026 Change — (€ million) (fx-adj.) Germany 175.4 194.2 +10.7 Net sales (€ million) EMEA 338.0 354.0 +4.3 +6.9% +7.8% Americas 120.6 140.9 +20.5 fx-adj fx-adj +7.4% +7.0% APAC 93.2 101.8 +12.2 nominal nominal 706 Total 727.2 790.9 +9.5 659 342 368 •
Slide 10: Key figures
Key figures 6M 2026 6M 2025 Change € million € million % Cash flow (from operating activities) 60.4 17.8 >+100 Investments 101.8 61.9 +64.3 Free cash flow 15.5 -42.0 >+100 Cash and cash equivalents1 198.5 177.4 +11.9 Net financial debt1 189.9 269.1 -29.4 Net financial debt1 / EBITDA2 0.5 0.9 Capital
Slide 11: Outlook FY 2026
03 Outlook FY 2026 Drägerwerk AG & Co. KGaA 11
Slide 12: Outlook
Outlook Results achieved Forecast for Current forecast for for fiscal year 2025 fiscal year 2026 fiscal year 2026 Net sales (net of currency effects) 5.3% 2.0 to 6.0% confirmed EBIT margin 6.7% 5.0 to 7.5% 6.0 to 8.0% Dräger Value Added (DVA) EUR 90.1 million EUR 20 to 120 million EUR 60 to 140 mill
Slide 13: Questions & Answers
Questions & Answers Drägerwerk AG & Co. KGaA 13
Slide 14: Financial calendar
Financial calendar Dräger publishes preliminary results approximately 2 weeks before the dates of the quarterly reports. Preliminary results for the full year are published in January. March 24, 2026 Annual Report 2025, Analysts‘ conference April 30, 2026 Report for the first three months 2026, Conf
Slide 15: Contact
Contact Visit our Investor Relations website: https://www.draeger.com/en-us_us/Investor-Relations Thomas Fischler Head of Treasury & Investor Relations Moislinger Alle 53-55 23558 Lübeck, Germany Tel. +49 451 882 2685 Mail: thomas.fischler@draeger.com Nikolaus Hammerschmidt Senior Manager Investor R
Slide 16: Thank you
Thank you Drägerwerk AG & Co. KGaA 16
Drägerwerk AG & Co. KGaA — H1 2026 Earnings Presentation on 6ix